Eric A. Collisson

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Supplementary Table S1 from Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies

  2026-06-17

• Supplementary Figures1 from Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies

  2026-06-17

• Supplementary Table S4 from Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies

  2026-06-17

• Data from Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies

  2026-06-17

• Supplementary Table S3 from Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies

  2026-06-17

• Supplementary Table S2 from Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies

  2026-06-17

• Abstract 1453: Association of interpretable histomorphic features with molecular markers: A Computational Histology Artificial Intelligence (CHAI) biomarker development platform analysis.

  Cancer Research · 2026-04-03

• Figure S2 from A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern Africa

  2025-11-26

• Figure S1 from A Genomic Analysis of Esophageal Squamous Cell Carcinoma in Eastern Africa

  2025-11-26

• Intratumoral Three-Cell-Type Clusters Are a Conserved Feature of Endogenous Antitumor Immunity

  Cancer Immunology Research · 2025-11-07 · 1 citations

• PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer

  Nature · 2025-05-21 · 36 citations

• PCSK9 dependent cholesterol acquisition and utilization underlies metastatic organ preference in pancreatic cancerPreprint

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-04-25

• Author response: Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep mutational scanning

  2025-02-17

• Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep mutational scanning

  eLife · 2025-02-17 · 5 citations

• Author response: Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep mutational scanning

  2025-01-23

• Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep mutational scanningPreprint

  eLife · 2025-01-23

• AI-Driven insights in pancreatic cancer imaging: from pre-diagnostic detection to prognostication

  Abdominal Radiology · 2024-12-30 · 9 citations

• Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep mutational scanningPreprint

  eLife · 2024-10-28

• Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep mutational scanning

  eLife · 2024-10-28 · 12 citations

• 363 (PB351): Ferrous Iron Reactive (FIRE) delivery of diagnostic or therapeutic agents

  European Journal of Cancer · 2024-10-01